Sfoglia per Autore
Unveiling the role of interleukine-1 Receptor in response to EGFR blockade
2017 Valerio Gelfo, Moshit Lindzen, Martina Mazzeschi, Giada Grilli, Rossella Solmi, Balazs Győrffy, Gabriele D’Uva, Yosef Yarden, Mattia Lauriola
A putative role for interleukin 1 pathway in resistance to EGFR blockade
2017 Valerio Gelfo, Martina Mazzeschi, Giada Grilli, Moshit Lindzen, Rossella Solmi, Gabriele D’Uva, Yosef Yarden, Mattia Lauriola
Modulation of ERBB signaling from tissue homeostasis to cancer progression
2018 Valerio Gelfo, Giada Grilli, Martina Mazzeschi, Moshit Lindzen, Rossella Solmi, Gabriele. D’Uva, Balazs. Győrffy, Yosef Yarden, Mattia Lauriola.
Molecular mechanisms of resistance to cetuximab mediated by IL-1 signaling
2018 Valerio Gelfo, Giada Grilli, Martina Mazzeschi, Moshit Lindzen, Spartaco Santi, Gabriele D’Uva, Yosef Yarden, Mattia Lauriola
A Novel Role for the Interleukin-1 Receptor Axis in Resistance to Anti-EGFR Therapy
2018 Gelfo V, Mazzeschi M, Grilli G, Lindzen Moshit, Santi Spartaco, D'Uva G, Győrffy B, Ardizzoni A, Yarden Y, Lauriola M.
Comparison of Sequential Testing and Next Generation Sequencing in advanced Lung Adenocarcinoma patients – A single centre experience
2020 Dall'Olio F.G.; Conci N.; Rossi G.; Fiorentino M.; De Giglio A.; Grilli G.; Altimari A.; Gruppioni E.; Filippini D.M.; Di Federico A.; Nuvola G.; Ardizzoni A.
Atezolizumab in a CoHort of pretreated, advanced, non-small cell lung cancer patients with rare HistologiCal SubtypEs (CHANCE trial)
2020 Gelsomino F.; Lamberti G.; Tiseo M.; Rocco D.; Pasello G.; Cecere F.L.; Chella A.; Grilli G.; Mandruzzato M.; Tognetto M.; Garassino M.C.; Macerelli M.; Novello S.; Roila F.; Colantonio I.; Grossi F.; Fiorentino M.; Ardizzoni A.
Roles of IL-1 in Cancer: From Tumor Progression to Resistance to Targeted Therapies
2020 Valerio Gelfo; Donatella Romaniello; Martina Mazzeschi; Michela Sgarzi; Giada Grilli; Alessandra Morselli; Beatrice Manzan; Karim Rihawi; Mattia Lauriola
PD-L1 Expression in Circulating Tumor Cells as a Promising Prognostic Biomarker in Advanced Non–small-cell Lung Cancer Treated with Immune Checkpoint Inhibitors
2021 Dall'Olio F.G.; Gelsomino F.; Conci N.; Marcolin L.; De Giglio A.; Grilli G.; Sperandi F.; Fontana F.; Terracciano M.; Fragomeno B.; Tober N.; Manferrari G.; Brocchi S.; Golfieri R.; Fiorentino M.; Ardizzoni A.
Comparative effectiveness of first-line immune checkpoint inhibitors plus tyrosine kinase inhibitors according to IMDC risk groups in metastatic renal cell carcinoma: A meta-analysis
2021 Rizzo A.; Mollica V.; Santoni M.; Rosellini M.; Marchetti A.; Ricci A.D.; Grilli G.; Greco A.; Montironi R.; Ardizzoni A.; Massari F.
Emerging Novel Therapeutic Approaches for Treatment of Advanced Cutaneous Melanoma
2022 Comito, Francesca; Pagani, Rachele; Grilli, Giada; Sperandi, Francesca; Ardizzoni, Andrea; Melotti, Barbara
| Titolo | Autore(i) | Anno | Periodico | Editore | Tipo | File |
|---|---|---|---|---|---|---|
| Unveiling the role of interleukine-1 Receptor in response to EGFR blockade | Valerio Gelfo, Moshit Lindzen, Martina Mazzeschi, Giada Grilli, Rossella Solmi, Balazs Győrffy, G...abriele D’Uva, Yosef Yarden, Mattia Lauriola | 2017-01-01 | - | - | 4.03 Poster | - |
| A putative role for interleukin 1 pathway in resistance to EGFR blockade | Valerio Gelfo, Martina Mazzeschi, Giada Grilli, Moshit Lindzen, Rossella Solmi, Gabriele D’Uva, Y...osef Yarden, Mattia Lauriola | 2017-01-01 | - | - | 4.01 Contributo in Atti di convegno | - |
| Modulation of ERBB signaling from tissue homeostasis to cancer progression | Valerio Gelfo, Giada Grilli, Martina Mazzeschi, Moshit Lindzen, Rossella Solmi, Gabriele. D’Uva, ...Balazs. Győrffy, Yosef Yarden, Mattia Lauriola. | 2018-01-01 | - | - | 4.02 Riassunto (Abstract) | - |
| Molecular mechanisms of resistance to cetuximab mediated by IL-1 signaling | Valerio Gelfo, Giada Grilli, Martina Mazzeschi, Moshit Lindzen, Spartaco Santi, Gabriele D’Uva, Y...osef Yarden, Mattia Lauriola | 2018-01-01 | - | - | 4.01 Contributo in Atti di convegno | - |
| A Novel Role for the Interleukin-1 Receptor Axis in Resistance to Anti-EGFR Therapy | Gelfo V, Mazzeschi M, Grilli G, Lindzen Moshit, Santi Spartaco, D'Uva G, Győrffy B, Ardizzoni A, ...Yarden Y, Lauriola M. | 2018-01-01 | CANCERS | - | 1.01 Articolo in rivista | - |
| Comparison of Sequential Testing and Next Generation Sequencing in advanced Lung Adenocarcinoma patients – A single centre experience | Dall'Olio F.G.; Conci N.; Rossi G.; Fiorentino M.; De Giglio A.; Grilli G.; Altimari A.; Gruppion...i E.; Filippini D.M.; Di Federico A.; Nuvola G.; Ardizzoni A. | 2020-01-01 | LUNG CANCER | - | 1.01 Articolo in rivista | - |
| Atezolizumab in a CoHort of pretreated, advanced, non-small cell lung cancer patients with rare HistologiCal SubtypEs (CHANCE trial) | Gelsomino F.; Lamberti G.; Tiseo M.; Rocco D.; Pasello G.; Cecere F.L.; Chella A.; Grilli G.; Man...druzzato M.; Tognetto M.; Garassino M.C.; Macerelli M.; Novello S.; Roila F.; Colantonio I.; Grossi F.; Fiorentino M.; Ardizzoni A. | 2020-01-01 | THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY | - | 1.01 Articolo in rivista | Gelsomino_CHANCE_TAMO'20.pdf |
| Roles of IL-1 in Cancer: From Tumor Progression to Resistance to Targeted Therapies | Valerio Gelfo; Donatella Romaniello; Martina Mazzeschi; Michela Sgarzi; Giada Grilli; Alessandra ...Morselli; Beatrice Manzan; Karim Rihawi; Mattia Lauriola | 2020-01-01 | INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES | - | 1.01 Articolo in rivista | ijms-21-06009.pdf |
| PD-L1 Expression in Circulating Tumor Cells as a Promising Prognostic Biomarker in Advanced Non–small-cell Lung Cancer Treated with Immune Checkpoint Inhibitors | Dall'Olio F.G.; Gelsomino F.; Conci N.; Marcolin L.; De Giglio A.; Grilli G.; Sperandi F.; Fontan...a F.; Terracciano M.; Fragomeno B.; Tober N.; Manferrari G.; Brocchi S.; Golfieri R.; Fiorentino M.; Ardizzoni A. | 2021-01-01 | CLINICAL LUNG CANCER | - | 1.01 Articolo in rivista | - |
| Comparative effectiveness of first-line immune checkpoint inhibitors plus tyrosine kinase inhibitors according to IMDC risk groups in metastatic renal cell carcinoma: A meta-analysis | Rizzo A.; Mollica V.; Santoni M.; Rosellini M.; Marchetti A.; Ricci A.D.; Grilli G.; Greco A.; Mo...ntironi R.; Ardizzoni A.; Massari F. | 2021-01-01 | IMMUNOTHERAPY | - | 1.01 Articolo in rivista | - |
| Emerging Novel Therapeutic Approaches for Treatment of Advanced Cutaneous Melanoma | Comito, Francesca; Pagani, Rachele; Grilli, Giada; Sperandi, Francesca; Ardizzoni, Andrea; Melott...i, Barbara | 2022-01-01 | CANCERS | - | 1.01 Articolo in rivista | cancers-14-00271-v2.pdf |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile